Description

Ropinirole Extended-Release (ER) Tablets (2 mg / 4 mg / 8 mg)

Healthy Inc is a specialized global supplier and exporter of advanced neurology, central nervous system (CNS), and geriatric therapeutics. We provide ultra-high-purity, kinetically controlled Ropinirole Hydrochloride Extended-Release Film-Coated Tablets (2 mg / 4 mg / 8 mg), manufactured in WHO–GMP certified, high-precision modified-release oral solid dosage facilities. This “Non-Ergoline Dopamine Agonist” is a highly lucrative, premium export to neurology centers, geriatric care networks, and government health ministries in LATAM, the Middle East, Africa, and Southeast Asia, serving as the globally mandated, 24-hour intervention for the continuous symptomatic control of idiopathic Parkinson’s Disease.

Product Overview

This highly advanced Extended-Release formulation utilizes a sophisticated structural matrix to slowly and continuously feed a potent dopamine mimic into the patient’s bloodstream over a full 24-hour cycle, eliminating the severe peaks and crashes associated with older therapies.

The “Continuous Dopaminergic Stimulation” Specialist:

• Mechanism 1 (The Direct Dopamine Mimic): In Parkinson’s Disease, the neurons in the brain that produce dopamine (the chemical responsible for smooth, coordinated muscle movement) slowly die off. Ropinirole is a highly selective non-ergoline agonist at the D2 and D3 dopamine receptors. It completely bypasses the dying neurons, crosses the blood-brain barrier, and binds directly to the receptors in the striatum, tricking the brain into thinking it has a normal supply of dopamine. This physically restores the patient’s ability to move smoothly and drastically reduces tremors, rigidity, and slowness (bradykinesia).
• Mechanism 2 (The 24-Hour ER Matrix Shield): Immediate-Release (IR) Parkinson’s drugs cause a massive spike of dopamine followed by a rapid crash. This rollercoaster effect causes severe “wearing-off” symptoms and violently uncontrollable jerking movements (dyskinesia). Our ER tablet utilizes an advanced polymer matrix that slowly hydrates in the stomach and intestines, steadily diffusing the Ropinirole over 24 hours. This provides smooth, continuous symptom control with just a single daily dose.
• The “Levodopa-Sparing” Advantage: Neurologists heavily prescribe Ropinirole ER as a first-line monotherapy in early Parkinson’s to delay the use of Levodopa. By holding off on Levodopa, it significantly delays the onset of severe, irreversible motor complications later in the patient’s life.

Product Composition & Strength

We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute stability of the modified-release polymers.

*Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 28/30 (Optimized specifically for strict 30-day chronic neurology dispensing regimens).

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Neurology Distributors, and Hospital Procurement Boards.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Hydrophilic Matrix Swelling Engineering: Manufacturing a reliable 24-hour ER tablet is highly complex. Our facilities utilize advanced high-viscosity Hypromellose (HPMC) blending. When the patient swallows the tablet, the gastrointestinal fluids interact with the HPMC, instantly forming a thick, gelatinous outer barrier. This gel barrier precisely controls the rate at which water enters the tablet and the rate at which the Ropinirole diffuses out, guaranteeing identical, zero-order pharmacokinetic release in every single batch.

Therapeutic Indications (Human Use)

Indicated for the targeted management of degenerative neurological motor dysfunction:

• Parkinson’s Disease: Treatment of the signs and symptoms of idiopathic Parkinson’s disease. May be used as early monotherapy or as an adjunct to levodopa therapy to smooth out “on-off” motor fluctuations.
• CRITICAL NOTE: Ropinirole Immediate-Release (IR) is often used for Restless Legs Syndrome (RLS), but the Extended-Release (ER) formulation is specifically indicated for Parkinson’s Disease.

Dosage & Administration

Recommended Dosage (Strictly as per Neurologist Guidelines):

• Standard Adult Dosing: Therapy must be initiated slowly at 2 mg once daily for 1 to 2 weeks, then gradually titrated upward by 2 mg increments to achieve optimal therapeutic response (typical maintenance range is 8 mg to 24 mg once daily).
• Administration (THE INTACT TABLET RULE): Tablets MUST be swallowed completely whole with water. They must never be chewed, crushed, or divided. Breaking the tablet physically destroys the ER polymer matrix, causing a massive, potentially fatal 24-hour dose of dopamine to dump into the patient’s system all at once.
• Discontinuation: Ropinirole must be tapered off slowly over 7 days to prevent Neuroleptic Malignant Syndrome (NMS)-like symptoms.

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• Sudden Sleep Onset (Sleep Attacks): Patients have reported falling asleep suddenly while engaged in daily activities, including operating motor vehicles, sometimes without any prior warning signs of drowsiness. Patients must be warned about driving or operating heavy machinery.
• Impulse Control Disorders (Signature Side Effect): Because Ropinirole floods the brain’s reward centers (D3 receptors), a significant number of patients develop intense, uncontrollable urges. This most commonly manifests as pathological gambling, hypersexuality, binge eating, or compulsive shopping. These behaviors usually resolve when the dose is reduced or stopped.
• Syncope & Severe Hypotension: Dopamine agonists can cause severe orthostatic hypotension (sudden blood pressure drop upon standing), leading to fainting (syncope), especially during dose escalation.
• Hallucinations & Psychosis: High levels of dopaminergic stimulation can trigger severe visual and auditory hallucinations, particularly in elderly patients.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and Retail Pharmacy Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Neurological and Modified-Release Formulations. Whether you are looking for a reliable Hospital Tender Supplier for CNS clinics in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Bulk Indenting, ensuring that every Authorized Medicine Wholesaler receives WHO-GMP certified products at competitive rates.